Repair Biotechnologies Employee Directory
Biotechnology ResearchNew York, United States2-10 Employees
Repair Biotechnologies is a small biotechnology research company based in Syracuse, New York. It pursues preclinical therapeutics aimed at cholesterol- and aging-related diseases, seeking to reverse disease processes driven by excess or modified cholesterol. The company’s work centers on a cholesterol-degrading approach intended to address conditions such as atherosclerosis and familial hypercholesterolemia. In November 2025, Repair Biotechnologies announced a collaboration with AGC Biologics to develop and manufacture a novel mRNA therapy intended to rapidly stabilize and reduce the size of atherosclerotic plaques. The company has expanded its scientific leadership with appointments to its Scientific Advisory Board, including endocrinologist Frederick J. Raal in October 2025 and cardiologist Deepak L. Bhatt in March 2025. These collaborations and leadership additions reflect ongoing efforts to advance its preclinical programs within the biotechnology research sector.